TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 4 | 3 | -1 | 12 | 16 | 52 | 14 |
| P | %wins | 100 | 50 | 50 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/27/16 16:26 | 6/23/16 | PRTK | Paratek Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bigham Michael | MA | DO | CB,CEO | P | 269 | 13.45 | 8 | 20 | 25 | 100 | D | 32 | -52 | -32 | -13 | -1 | -23 | -22 | -3 | 6 | 9 | 4 | 8 | 6 | |
3/26/13 16:33 | 3/20/13 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bigham Michael | MA | D | P.dm | 189 | 5.41 | 2 | 35 | New | 35 | I | -45 | -19 | -23 | -24 | -15 | 7 | 1 | -4 | -6 | 16 | 25 | 52 | |||
8/15/05 18:25 | 8/11/05 | XGEN | Xenogen Corp | DE | Electr | LabEq | Measuring & Controlling Devic | Bigham Michael | CA | DT | P.d | 4,000 | 2.91 | 0 | 1,375 | 79 | 3,121 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |